Nektar Therapeutics · NASDAQ:NKTR
The Vanguard Group's stake in Nektar Therapeutics fell below 5% (Schedule 13G/A)
Event Mar 13, 2026 · Filed Mar 27, 2026
The Vanguard Group's stake in Nektar Therapeutics fell below 5%, 0 shares, as a passive investor on Mar 13, 2026. Filed Mar 27, 2026 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 0% | 0 |
Source
Related
- Nektar Therapeutics
- The Vanguard Group
- Nektar Therapeutics shareholders
- Schedule 13G · The Vanguard Group · Jan 30, 2026
- Schedule 13G/A · The Vanguard Group · Oct 31, 2025
- Schedule 13G/A · Two Seas Capital LP · Sep 28, 2026
- Form 4 · Whitfield Roy A · Sep 25, 2026
- Form 4 · Greer R Scott · Sep 25, 2026
- Form 4 · Chess Robert · Sep 25, 2026
- Form 4 · Brainard Diana · Sep 25, 2026